EMBECTA CORP (EMBC) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:EMBC • US29082K1051

10.3 USD
-0.56 (-5.2%)
At close: Feb 9, 2026
10.36 USD
+0.06 (+0.58%)
After Hours: 2/9/2026, 8:00:02 PM
Fundamental Rating

6

EMBC gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. EMBC has an excellent profitability rating, but there are some minor concerns on its financial health. EMBC may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • EMBC had positive earnings in the past year.
  • In the past year EMBC had a positive cash flow from operations.
  • Each year in the past 5 years EMBC has been profitable.
  • In the past 5 years EMBC always reported a positive cash flow from operatings.
EMBC Yearly Net Income VS EBIT VS OCF VS FCFEMBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

1.2 Ratios

  • With an excellent Return On Assets value of 8.75%, EMBC belongs to the best of the industry, outperforming 90.86% of the companies in the same industry.
  • The Return On Invested Capital of EMBC (27.81%) is better than 98.92% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for EMBC is significantly above the industry average of 8.79%.
  • The last Return On Invested Capital (27.81%) for EMBC is above the 3 year average (22.63%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.75%
ROE N/A
ROIC 27.81%
ROA(3y)6.88%
ROA(5y)18.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)22.63%
ROIC(5y)31.94%
EMBC Yearly ROA, ROE, ROICEMBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

1.3 Margins

  • Looking at the Profit Margin, with a value of 8.83%, EMBC belongs to the top of the industry, outperforming 82.26% of the companies in the same industry.
  • In the last couple of years the Profit Margin of EMBC has declined.
  • EMBC has a Operating Margin of 30.50%. This is amongst the best in the industry. EMBC outperforms 97.31% of its industry peers.
  • In the last couple of years the Operating Margin of EMBC has declined.
  • With a decent Gross Margin value of 63.85%, EMBC is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • EMBC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 30.5%
PM (TTM) 8.83%
GM 63.85%
OM growth 3Y-5.72%
OM growth 5Y-7.43%
PM growth 3Y-23.59%
PM growth 5Y-25.86%
GM growth 3Y-2.36%
GM growth 5Y-1.89%
EMBC Yearly Profit, Operating, Gross MarginsEMBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 20 40 60

4

2. Health

2.1 Basic Checks

  • EMBC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • EMBC has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, EMBC has more shares outstanding
  • EMBC has a worse debt/assets ratio than last year.
EMBC Yearly Shares OutstandingEMBC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
EMBC Yearly Total Debt VS Total AssetsEMBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • EMBC has an Altman-Z score of 2.03. This is not the best score and indicates that EMBC is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.03, EMBC is in the better half of the industry, outperforming 63.98% of the companies in the same industry.
  • The Debt to FCF ratio of EMBC is 7.84, which is on the high side as it means it would take EMBC, 7.84 years of fcf income to pay off all of its debts.
  • EMBC has a Debt to FCF ratio of 7.84. This is in the better half of the industry: EMBC outperforms 74.19% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.84
Altman-Z 2.03
ROIC/WACC3.51
WACC7.92%
EMBC Yearly LT Debt VS Equity VS FCFEMBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 2.41 indicates that EMBC has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.41, EMBC is in line with its industry, outperforming 47.85% of the companies in the same industry.
  • EMBC has a Quick Ratio of 1.73. This is a normal value and indicates that EMBC is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.73, EMBC perfoms like the industry average, outperforming 47.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.41
Quick Ratio 1.73
EMBC Yearly Current Assets VS Current LiabilitesEMBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

4

3. Growth

3.1 Past

  • EMBC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.72%, which is quite impressive.
  • Measured over the past years, EMBC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -26.21% on average per year.
  • EMBC shows a decrease in Revenue. In the last year, the revenue decreased by -3.80%.
  • EMBC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.10% yearly.
EPS 1Y (TTM)20.72%
EPS 3Y-25.33%
EPS 5Y-26.21%
EPS Q2Q%9.23%
Revenue 1Y (TTM)-3.8%
Revenue growth 3Y-1.47%
Revenue growth 5Y-0.1%
Sales Q2Q%-0.27%

3.2 Future

  • EMBC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.66% yearly.
  • EMBC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.59% yearly.
EPS Next Y-0.06%
EPS Next 2Y0.71%
EPS Next 3Y0.66%
EPS Next 5YN/A
Revenue Next Year-0.18%
Revenue Next 2Y0.05%
Revenue Next 3Y0.21%
Revenue Next 5Y1.59%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EMBC Yearly Revenue VS EstimatesEMBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
EMBC Yearly EPS VS EstimatesEMBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

8

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 3.40, which indicates a rather cheap valuation of EMBC.
  • 99.46% of the companies in the same industry are more expensive than EMBC, based on the Price/Earnings ratio.
  • EMBC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.06.
  • Based on the Price/Forward Earnings ratio of 3.42, the valuation of EMBC can be described as very cheap.
  • EMBC's Price/Forward Earnings ratio is rather cheap when compared to the industry. EMBC is cheaper than 100.00% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.86. EMBC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 3.4
Fwd PE 3.42
EMBC Price Earnings VS Forward Price EarningsEMBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 98.39% of the companies in the same industry are more expensive than EMBC, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of EMBC indicates a rather cheap valuation: EMBC is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.3
EV/EBITDA 4.88
EMBC Per share dataEMBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 15

4.3 Compensation for Growth

  • The decent profitability rating of EMBC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.71%
EPS Next 3Y0.66%

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 5.52%, EMBC is a good candidate for dividend investing.
  • In the last 3 months the price of EMBC has falen by -29.21%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 0.20, EMBC pays a better dividend. On top of this EMBC pays more dividend than 100.00% of the companies listed in the same industry.
  • EMBC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 5.52%

5.2 History

  • EMBC has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
EMBC Yearly Dividends per shareEMBC Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • EMBC pays out 36.69% of its income as dividend. This is a sustainable payout ratio.
DP36.69%
EPS Next 2Y0.71%
EPS Next 3Y0.66%
EMBC Yearly Income VS Free CF VS DividendEMBC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
EMBC Dividend Payout.EMBC Dividend Payout, showing the Payout Ratio.EMBC Dividend Payout.PayoutRetained Earnings

EMBECTA CORP

NASDAQ:EMBC (2/9/2026, 8:00:02 PM)

After market: 10.36 +0.06 (+0.58%)

10.3

-0.56 (-5.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-05
Earnings (Next)05-07
Inst Owners99.49%
Inst Owner Change0.24%
Ins Owners1.29%
Ins Owner Change28.53%
Market Cap602.65M
Revenue(TTM)1.08B
Net Income(TTM)95.40M
Analysts51.11
Price Target17 (65.05%)
Short Float %6.65%
Short Ratio5.55
Dividend
Industry RankSector Rank
Dividend Yield 5.52%
Yearly Dividend0.6
Dividend Growth(5Y)N/A
DP36.69%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)16.51%
Min EPS beat(2)-8.66%
Max EPS beat(2)41.68%
EPS beat(4)3
Avg EPS beat(4)26.75%
Min EPS beat(4)-8.66%
Max EPS beat(4)44.01%
EPS beat(8)7
Avg EPS beat(8)35.11%
EPS beat(12)9
Avg EPS beat(12)26.08%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.77%
Min Revenue beat(2)-2.58%
Max Revenue beat(2)4.13%
Revenue beat(4)2
Avg Revenue beat(4)0.59%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)4.13%
Revenue beat(8)5
Avg Revenue beat(8)1.57%
Revenue beat(12)9
Avg Revenue beat(12)1.87%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.96%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.83%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)-0.18%
Valuation
Industry RankSector Rank
PE 3.4
Fwd PE 3.42
P/S 0.56
P/FCF 3.3
P/OCF 3.14
P/B N/A
P/tB N/A
EV/EBITDA 4.88
EPS(TTM)3.03
EY29.42%
EPS(NY)3.01
Fwd EY29.25%
FCF(TTM)3.12
FCFY30.27%
OCF(TTM)3.28
OCFY31.81%
SpS18.47
BVpS-11.12
TBVpS-11.5
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 8.75%
ROE N/A
ROCE 39.73%
ROIC 27.81%
ROICexc 38.19%
ROICexgc 39.66%
OM 30.5%
PM (TTM) 8.83%
GM 63.85%
FCFM 16.88%
ROA(3y)6.88%
ROA(5y)18.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)22.63%
ROIC(5y)31.94%
ROICexc(3y)32.83%
ROICexc(5y)43.39%
ROICexgc(3y)34.19%
ROICexgc(5y)45.56%
ROCE(3y)32.33%
ROCE(5y)45.63%
ROICexgc growth 3Y-16%
ROICexgc growth 5Y-7.86%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y-7.62%
OM growth 3Y-5.72%
OM growth 5Y-7.43%
PM growth 3Y-23.59%
PM growth 5Y-25.86%
GM growth 3Y-2.36%
GM growth 5Y-1.89%
F-Score6
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.84
Debt/EBITDA 3.83
Cap/Depr 22.85%
Cap/Sales 0.86%
Interest Coverage 3.17
Cash Conversion 51.78%
Profit Quality 191.2%
Current Ratio 2.41
Quick Ratio 1.73
Altman-Z 2.03
F-Score6
WACC7.92%
ROIC/WACC3.51
Cap/Depr(3y)49.26%
Cap/Depr(5y)65.23%
Cap/Sales(3y)1.54%
Cap/Sales(5y)2.02%
Profit Quality(3y)91.71%
Profit Quality(5y)109.85%
High Growth Momentum
Growth
EPS 1Y (TTM)20.72%
EPS 3Y-25.33%
EPS 5Y-26.21%
EPS Q2Q%9.23%
EPS Next Y-0.06%
EPS Next 2Y0.71%
EPS Next 3Y0.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.8%
Revenue growth 3Y-1.47%
Revenue growth 5Y-0.1%
Sales Q2Q%-0.27%
Revenue Next Year-0.18%
Revenue Next 2Y0.05%
Revenue Next 3Y0.21%
Revenue Next 5Y1.59%
EBIT growth 1Y47.56%
EBIT growth 3Y-7.11%
EBIT growth 5Y-7.53%
EBIT Next Year15.9%
EBIT Next 3Y4.95%
EBIT Next 5YN/A
FCF growth 1Y816.58%
FCF growth 3Y-22.26%
FCF growth 5Y-16.78%
OCF growth 1Y436.98%
OCF growth 3Y-22.52%
OCF growth 5Y-17.41%

EMBECTA CORP / EMBC FAQ

What is the fundamental rating for EMBC stock?

ChartMill assigns a fundamental rating of 6 / 10 to EMBC.


What is the valuation status for EMBC stock?

ChartMill assigns a valuation rating of 8 / 10 to EMBECTA CORP (EMBC). This can be considered as Undervalued.


Can you provide the profitability details for EMBECTA CORP?

EMBECTA CORP (EMBC) has a profitability rating of 7 / 10.


What are the PE and PB ratios of EMBECTA CORP (EMBC) stock?

The Price/Earnings (PE) ratio for EMBECTA CORP (EMBC) is 3.4 and the Price/Book (PB) ratio is -0.93.


Can you provide the expected EPS growth for EMBC stock?

The Earnings per Share (EPS) of EMBECTA CORP (EMBC) is expected to decline by -0.06% in the next year.